Avenue Therapeutics Statistics
Total Valuation
ATXI has a market cap or net worth of $1.93 million. The enterprise value is -$668,466.
Important Dates
The next estimated earnings date is Monday, March 17, 2025, after market close.
| Earnings Date | Mar 17, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ATXI has 1.91 million shares outstanding. The number of shares has increased by 933.39% in one year.
| Current Share Class | 1.91M |
| Shares Outstanding | 1.91M |
| Shares Change (YoY) | +933.39% |
| Shares Change (QoQ) | +43.16% |
| Owned by Insiders (%) | 1.18% |
| Owned by Institutions (%) | 3.20% |
| Float | 1.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.62 |
| P/TBV Ratio | 0.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.70
| Current Ratio | 2.70 |
| Quick Ratio | 2.67 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -471.94% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -714.65% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$6.09M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.46% in the last 52 weeks. The beta is -0.29, so ATXI's price volatility has been lower than the market average.
| Beta (5Y) | -0.29 |
| 52-Week Price Change | -91.46% |
| 50-Day Moving Average | 1.59 |
| 200-Day Moving Average | 2.45 |
| Relative Strength Index (RSI) | 25.97 |
| Average Volume (20 Days) | 78,525 |
Short Selling Information
The latest short interest is 92,162, so 4.82% of the outstanding shares have been sold short.
| Short Interest | 92,162 |
| Short Previous Month | 154,915 |
| Short % of Shares Out | 4.82% |
| Short % of Float | 6.81% |
| Short Ratio (days to cover) | 0.10 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.81M |
| Pretax Income | -5.87M |
| Net Income | -18.28M |
| EBITDA | n/a |
| EBIT | -11.81M |
| Earnings Per Share (EPS) | -$20.51 |
Full Income StatementBalance Sheet
The company has $2.60 million in cash and n/a in debt, giving a net cash position of $2.60 million or $1.36 per share.
| Cash & Cash Equivalents | 2.60M |
| Total Debt | n/a |
| Net Cash | 2.60M |
| Net Cash Per Share | $1.36 |
| Equity (Book Value) | 1.65M |
| Book Value Per Share | 1.63 |
| Working Capital | 1.65M |
Full Balance SheetCash Flow
| Operating Cash Flow | -10.59M |
| Capital Expenditures | n/a |
| Free Cash Flow | -10.59M |
| FCF Per Share | -$5.54 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |